Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

COVID-19 infection can significantly cause temporary hair loss.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

About 61% of women who had COVID-19 experienced hair loss afterward.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

An 86-year-old man had a rare tongue melanoma but refused treatment, showing the need for early cancer detection and treatment.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Hair restoration surgery can be safely done without major bleeding in patients on antithrombotic therapy, and these drugs shouldn't be stopped before surgery.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.